Ambrx
Manan Patel, MS, RPh, is a seasoned clinical R&D leader with extensive experience in drug and biologic development across various therapeutic areas. Currently serving as a Clinical R&D Lead at Ambrx since May 2022, Manan has a robust history of overseeing clinical studies, coordinating with Contract Research Organizations (CROs), and managing clinical budgets. Prior roles include leadership positions at Mrk, Amg, Celg, Nvs, Taro Pharmaceuticals, and Viatris, where Manan was responsible for clinical planning, study site management, and regulatory submissions for diverse clinical trials. Manan holds a Bachelor's degree in Pharmacy from Maharashtra University of Health Sciences and a Master's degree in Pharmacy with a focus on Pharmacology from the University of Mumbai.
This person is not in any offices
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.